Three Cases of Malignant Pleural Mesothelioma Misdiagnosed as Tuberculous Pleurisy

Malignant pleural mesothelioma(MPM) is an uncommon neoplasm which is originated from pleural mesothelial cells. The majority of MPM is associated with prior asbestos exposure. Patients often present with chest pain and dyspnea due to pleural effusion, which might be diagnosed with tuberculous pleurisy especially in Korea. MPM is well known for its poor prognosis with a median survival time of less than 12 months after diagnosis and no established standard treatment modality. We report 3 cases of MPM confirmed by video-assisted thoracoscopic biopsy first misdiagnosed as tuberculous pleurisy. (Tuberc Respir Dis 2007; 62: 323-330)

keywords: Malignant pleural mesothelioma, Tuberculous pleurisy, Thoracoscopy, Malignant pleural mesothelioma, Tuberculous pleurisy, Thoracoscopy

Reference

1.Ordonez NG. The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma. Am J Surg Pathol 1989,

et al. Clinical review on two cases of pleural mesothelioma. Tuberc Respir Dis 1977,

Rhee YK. A case of malignant mesothelioma with pleural effusion. Tuberc Respir Dis 1983,

et al. A case of malignant mesothelioma of pleura associated with hypoglycemia. Tuberc Respir Dis 1990,

et al. Clinical study on mesothelioma of the pleura. Tuberc Respir Dis 1991,

(1995) A case of diffuse malignant pleural mesothelioma with occupational asbestos exposure,

(1997) Differentiation between malignant pleural mesothelioma and metastasis of the pleura: CT evaluation,

(1998) A case of malignant pleural mesothelioma combined with asbestosis in a boilermaker and plumber,

(1999) Analysis of pulmonary asbestos body in malignant mesothelioma,

10.

(2000) Malignant mesothelioma with hypoglycemia,

11.

Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960,

12.

Bignon J. Asbestos retention in human respiratory tissues comparative measurements in lung parenchyma and in parietal pleura. IARC Sci Publ 1980,

13.

(1996) Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor ,

14.

(2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma,

15.

(2002) A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma,

바로가기메뉴

Article Contents

Vol.62 No.4

Three Cases of Malignant Pleural Mesothelioma Misdiagnosed as Tuberculous Pleurisy

Abstract

Reference

Tuberculosis & Respiratory Diseases